Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 106

1.

Official ATS/JRS Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

Harari S, Cassandro R, Torre O.

Am J Respir Crit Care Med. 2017 Mar 13. doi: 10.1164/rccm.201702-0272LE. [Epub ahead of print] No abstract available.

PMID:
28288282
2.

Epidemiology, survival, incidence and prevalence of idiopathic pulmonary fibrosis in the USA and Canada.

Harari S, Caminati A, Madotto F, Conti S, Cesana G.

Eur Respir J. 2017 Jan 25;49(1). pii: 1601504. doi: 10.1183/13993003.01504-2016. Print 2017 Jan. No abstract available.

PMID:
28122864
3.

Out with the old, in with the new for the European Respiratory Review.

Harari S.

Eur Respir Rev. 2017 Jan 3;26(143). pii: 160118. doi: 10.1183/16000617.0118-2016. Print 2017 Jan. No abstract available.

4.

The revolution of pulmonary arterial hypertension.

Harari S.

Eur Respir Rev. 2016 Dec;25(142):361-363. doi: 10.1183/16000617.0102-2016. No abstract available.

5.

99mTc-Sestamibi Avid Soft Tissue Lesions in Rosai-Dorfman Disease.

Wong PK, Lee DJ, Harari S, Barron BJ.

Clin Nucl Med. 2016 Dec;41(12):e508-e510.

PMID:
27824326
6.

Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective.

Bassi I, Hollis G, Cottin V, Harari S, Zwanenburg E, Veltkamp M, Casanova A, Fletcher M, Masefield S, Powell P, Boyd J.

ERJ Open Res. 2016 Apr 21;2(2). pii: 00102-2015. eCollection 2016 Apr 21.

7.

Adding new perspectives to the European Respiratory Review.

Harari S.

Eur Respir Rev. 2016 Sep;25(141):221-2. doi: 10.1183/16000617.0045-2016. No abstract available.

8.

Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.

CaliĆ² A, Eble JN, Hes O, Martignoni G, Harari SE, Williamson SR, Brunelli M, Osunkoya AO, Wang L, Comperat E, Lopez-Beltran A, Wang M, Zhang S, Curless KL, Post KM, Chang HY, Luchini C, Baldrige LA, MacLennan GT, Montironi R, Grignon DJ, Cheng L.

Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11117. [Epub ahead of print]

9.

Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.

Harari S, Elia D, Torre O, Bulgheroni E, Provasi E, Moss J.

Chest. 2016 Aug;150(2):e29-32. doi: 10.1016/j.chest.2016.02.654.

PMID:
27502989
10.

Data sharing: When better may be the enemy of good.

Harari S.

Eur J Intern Med. 2016 Sep;33:e28-9. doi: 10.1016/j.ejim.2016.06.003. Epub 2016 Jun 28. No abstract available.

PMID:
27363305
11.

Thoracic involvement in generalised lymphatic anomaly (or lymphangiomatosis).

Luisi F, Torre O, Harari S.

Eur Respir Rev. 2016 Jun;25(140):170-7. doi: 10.1183/16000617.0018-2016. Review.

12.

Why we should care about ultra-rare disease.

Harari S.

Eur Respir Rev. 2016 Jun;25(140):101-3. doi: 10.1183/16000617.0017-2016. No abstract available.

13.

Toward better management of rare and orphan pulmonary diseases.

Harari S, Humbert M.

Eur Respir J. 2016 May;47(5):1334-5. doi: 10.1183/13993003.00390-2016. No abstract available.

PMID:
27132268
14.

The goal is to go further and do better: but how?

Harari S.

Eur Respir Rev. 2016 Mar;25(139):1-3. doi: 10.1183/16000617.0094-2015. No abstract available.

15.

Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.

Harari S, Madotto F, Caminati A, Conti S, Cesana G.

PLoS One. 2016 Feb 3;11(2):e0147072. doi: 10.1371/journal.pone.0147072. eCollection 2016 Feb 3.

16.

Primary mucinous adenocarcinoma of the female urethra: a contemporary clinicopathologic analysis.

Harari SE, Cheng L, Osunkoya AO.

Hum Pathol. 2016 Jan;47(1):132-7. doi: 10.1016/j.humpath.2015.09.014. Epub 2015 Sep 30.

PMID:
26552875
17.

The changing face of a rare disease: lymphangioleiomyomatosis.

Harari S, Torre O, Cassandro R, Moss J.

Eur Respir J. 2015 Nov;46(5):1471-85. doi: 10.1183/13993003.00412-2015. Epub 2015 Sep 24. Review.

PMID:
26405290
18.

Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation.

Caminati A, Madotto F, Cesana G, Conti S, Harari S.

Eur Respir Rev. 2015 Sep;24(137):436-44. doi: 10.1183/16000617.0040-2015. Review.

19.

Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences.

Harari S, Caminati A.

Eur Respir Rev. 2015 Sep;24(137):420-7. doi: 10.1183/16000617.0042-2015. Review.

20.

Pulmonary hypertension in patients with chronic myeloproliferative disorders.

Adir Y, Elia D, Harari S.

Eur Respir Rev. 2015 Sep;24(137):400-10. doi: 10.1183/16000617.0041-2015. Review.

Supplemental Content

Loading ...
Support Center